Loading…

Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor

[Display omitted] 9 N-alkylated derivatives of dextromethorphan are synthesized and studied as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptors (nAChRs). In vitro activity towards α3β4 nicotinic acetylcholine receptor is determined using a patch-clamp technique and is in the micr...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2014-12, Vol.22 (24), p.6846-6856
Main Authors: Jozwiak, Krzysztof, Targowska-Duda, Katarzyna M., Kaczor, Agnieszka A., Kozak, Joanna, Ligeza, Agnieszka, Szacon, Elzbieta, Wrobel, Tomasz M., Budzynska, Barbara, Biala, Grazyna, Fornal, Emilia, Poso, Antti, Wainer, Irving W., Matosiuk, Dariusz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] 9 N-alkylated derivatives of dextromethorphan are synthesized and studied as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptors (nAChRs). In vitro activity towards α3β4 nicotinic acetylcholine receptor is determined using a patch-clamp technique and is in the micromolar range. Homology modeling, molecular docking and molecular dynamics of ligand-receptor complexes in POPC membrane are used to find the mode of interactions of N-alkylated dextromethorphan derivatives with α3β4 nAChR. The compounds, similarly as dextromethorphan, interact with the middle portion of α3β4 nAChR ion channel. Finally, behavioral tests confirmed potential application of the studied compounds for the treatment of addiction.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2014.10.036